International contributions

  • COVID-19 Health System Response Monitor

The KCE is the Belgian correspondent of the European Observatory on Health Systems and Policies, which is part of the World Health Organisation (WHO). In this context, we have been asked to keep a “crisis diary” for Belgium on an international platform set up to analyse the responses of each country to the epidemic. This initiative will undoubtedly make it possible to carry out interesting analyses a posteriori and to draw valuable lessons for the future.

  • EUnetHTA COVID-19 response – Rolling Collaborative Reviews on COVID-19

The KCE is part of the European health technology assessment network EUnetHTA. In the context of the COVID-19 pandemic, this network launched Rolling Collaborative Reviews (RCRs) to provide health authorities with rapid and scientifically sound information on the comparative effectiveness of 15 treatments currently used against this virus. The first round of these monthly updated reviews was published in August 2020 and is updated monthly. KCE is covering the generic drugs camostat and nafamostat.

Some KCE experts also participated in an EUnetHTA Rapid Collaborative Review on some diagnostic tests.

  • Participation in the Scientific Advisory Board EU-RESPONSE

The European Scientific Advisory Board EU-RESPONSE is a research and preparedness network for pandemics and emerging infectious diseases (EU-RESPONSE). It is a 5-year multinational project coordinated by INSERM (France). It is funded by the European Union’s Horizon 2020 Research and Innovation programme to design an adaptive European platform for clinical trials for COVID-19 and other emerging infectious diseases (SolidAct Trial) in order to assess the efficacy and safety of medicines. Hospitals from all over Europe may be involved in this framework. A researcher from KCE is part of the independent Scientific and Ethical Advisory Board set up to advise on the structure of the platform EU-SolidAct, and on the priority in which the medicines should be studied.